No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
CA Stock MarketDetailed Quotes
NGEN NervGen Pharma Corp
- 2.920
- +0.020+0.69%
15min DelayMarket Closed Jul 24 16:00 ET
204.19MMarket Cap-8588P/E (TTM)
2.980High2.850Low65.46KVolume2.930Open2.900Pre Close191.04KTurnover3.98052wk High0.12%Turnover Ratio69.93MShares1.58052wk Low-0.34EPS TTM161.20MFloat Cap3.980Historical HighLossP/E (Static)55.20MShs Float0.800Historical Low-0.38EPS LYR4.48%Amplitude--Dividend TTM10.86P/B1Lot Size--Div YieldTTM
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
NervGen Pharma to Advance New Drug Candidate Into Preclinical Proof-of-Concept Stage
NervGen Pharma Corp. Price Target Announced at C$4.00/Share by Stifel Nicolaus
NervGen Pharma Closes C$23 Million Bought Deal Financing
NervGen Pharma Raising C$20.1 Million in Bought-Deal Offering of Share Units
NervGen Pharma Extends the Expiry Date of Certain Stock Options
NervGen Pharma Corp. (CVE:NGEN) Shares Could Be 42% Below Their Intrinsic Value Estimate
Heat List
CA
Overall
Symbol
Latest Price
%Chg